Approximately one-third of patients with MYH9-related disorder have kidney dysfunction (35–37) characterized by progressive proteinuria, glomerulosclerosis with foot process effacement, and kidney failure (36–38). This evidence concerns the gene MYH9 and glomerulosclerosis.